Vishay Intertechnology Maintains 2028 Guidance But Faces Macroeconomic Headwinds
Developing story — details emerging. Check the source link for the latest updates.
2 headlines
Developing story — details emerging. Check the source link for the latest updates.
On this episode of Stock Movers with Alexis Christoforous: - Nuvalent (NUVL) shares are higher on news GSK agreed to buy Nuvalent for $10. 6 billion, securing a US biotech firm developing treatments for lung cancer. - JM Smucker (SJM) shares are on the move after it posted fourth-quarter profit...